Arrowhead Pharmaceuticals Inc
Biotechnology
Healthcare
ARWR
134 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
32.06
52 week high
32.50
high
33.00
52 week low
0.00
low
31.59
growth
56.25 %
previous Close
32.05
P/E ratio
market cap
2.27 B
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
-67.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top